The ProVision Board has appointed Ms Frances Mirabelli as its next CEO, commencing Monday 14 February 2022. She takes over from Mr Steven Johnston who left the organisation on 27 January, after 10 years in the role.
Sunglass Collective takes out top customer service award
Melbourne-based distributor Sunglass Collective has been lauded for its outstanding customer service, winning the 2021 Australian Achiever Award in the Optical Services and Supplies business category. Read more
Alcon announces APAC leadership reshuffle
Alcon has announced two new appointments to lead the company’s surgical and vision care franchises in Asia Pacific (APAC) region. Read more
Specsavers unveils AU$110 million investment for Canada expansion plans
Specsavers has announced it will invest AU$110 million to cover the full clinic and optical store start-up costs for new partners as the company pursues its first foray into the North American market. Read more
Glaukos trials eyelid cream to treat presbyopia and dry eye
Glaukos has commenced Phase 2 trials of two investigational cream-based drug candidates that are applied to the eyelids to treat dry eye and presbyopia. Read more
Eyecare spin-off Bausch + Lomb files for IPO
Almost 18 months since its parent company announced Bausch + Lomb (B+L) would be spun off as a pure-play eye health company, the entity has filed for an initial public offering (IPO) on the New York and Toronto stock exchanges. Read more
Healthia to acquire LensPro Optometrists
ASX-listed Healthia has entered into a binding agreement to acquire the eight-practice business LensPro Optometrists, securing its largest optometry acquisition since its 2020 takeover of The Optical Company. Read more
Mojo Vision eyes fitness wearables market with smart contact lens
Smart contact lens startup Mojo Vision has signed strategic partnerships with leading sports and fitness brands. The company says it has identified an opportunity in the wearables market to deliver real-time performance data to athletes through its hands-free, eye-controlled user interface. Read more
Novartis targets GA gene therapy in Gyroscope Therapeutics deal
Novartis has announced it is acquiring Gyroscope Therapeutics, the UK-based company behind an investigational dry ADM gene therapy that is the focus of key clinical trials in Australia. Read more
Breaking the mould: understanding Peter Larsen
In a wide-ranging interview, PETER LARSEN details his rationale for bringing Specsavers to Australia, as well as the opposition he’s faced trying to change optometry’s ‘belief systems’. He also discusses his new roles at Topcon and the Centre for Eye Research Australia. Read more